These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 725503)

  • 1. Radioimmunoassay of vasoactive intestinal polypeptide in plasma.
    Burhol PG; Lygren I; Waldum HL
    Scand J Gastroenterol; 1978; 13(7):807-13. PubMed ID: 725503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunoassay of secretin in acidified plasma.
    Burhol PG; Waldum HL
    Acta Hepatogastroenterol (Stuttg); 1978 Dec; 25(6):474-81. PubMed ID: 726817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioimmunoassay of vasoactive intestinal polypeptide (VIP) in plasma.
    Fahrenkrug J; Schaffalitzky de Muckadell OV
    J Lab Clin Med; 1977 Jun; 89(6):1379-88. PubMed ID: 325156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production and evaluation of secretin antibodies.
    Burhol PG; Waldum HL
    Acta Hepatogastroenterol (Stuttg); 1978 Apr; 25(2):139-43. PubMed ID: 654847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunoassay for vasoactive intestinal polypeptide (VIP) in plasma before and during endoscopic examinations.
    Hossdorf T; Burger M; Burger M; Karoff C; van Husen N; Wagner H
    Hepatogastroenterology; 1982 Aug; 29(4):146-50. PubMed ID: 7129338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of duodenal infusion of graded doses of HCL on plasma secretin and vasoactive intestinal polypeptide (VIP), and on duodenal bicarbonate secretion in man.
    Lygren I; Burhol PG; Waldum HL; Jorde R
    Mater Med Pol; 1980; 12(4):223-8. PubMed ID: 7266047
    [No Abstract]   [Full Text] [Related]  

  • 7. Production and evaluation of antibodies for radioimmunoassay of secretin.
    Fahrenkrug J; Muckadell OB; Rehfeld JF
    Scand J Clin Lab Invest; 1976 May; 36(3):281-7. PubMed ID: 940982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunoassay of vasoactive intestinal polypeptide.
    Chang TM; Roth FL; Tai HH; Chey WY
    Anal Biochem; 1979 Sep; 97(2):286-97. PubMed ID: 525792
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of a test meal on plasma vasoactive intestinal polypeptide (VIP), gastric inhibitory polypeptide (GIP), and secretin in man.
    Burhol PG; Waldum HL; Jorde R; Lygren I
    Scand J Gastroenterol; 1979; 14(8):939-43. PubMed ID: 531513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of fasting and postprandial plasma VIP in man.
    Mitchell SJ; Bloom SR
    Gut; 1978 Nov; 19(11):1043-8. PubMed ID: 730071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of VIP, secretin and motilin after duodenal acidification in man.
    Bloom SR; Mitchell SJ; Greenberg GR; Christofides N; Domschke W; Domschke S; Mitznegg P; Demling L
    Acta Hepatogastroenterol (Stuttg); 1978 Oct; 25(5):365-8. PubMed ID: 726803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasting and prolonged exercise increase vasoactive intestinal polypeptide (VIP) in plasma.
    Galbo H; Hilsted J; Fahrenkrug J; Schaffalitzky De Muckadell OB
    Acta Physiol Scand; 1979 Mar; 105(3):374-7. PubMed ID: 443066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of duodenal infusion of bile on plasma VIP, GIP, and secretin and on duodenal bicarbonate secretion.
    Burhol PG; Lygren I; Waldum HL; Jorde R
    Scand J Gastroenterol; 1980; 15(8):1007-11. PubMed ID: 7233065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoactive intestinal polypeptide (VIP) in children with neural crest tumours.
    Scheibel E; Rechnitzer C; Fahrenkrug J; Hertz H
    Acta Paediatr Scand; 1982 Sep; 71(5):721-5. PubMed ID: 6295059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic approach to the preparation of 125I-labeled gastrointestinal regulatory peptides with high specific radioactivities.
    Burhol PG; Jorde R; Florholmen J; Jenssen TG; Vonen B
    Scand J Gastroenterol; 1985 May; 20(4):466-9. PubMed ID: 2862690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific binding sites for vasoactive intestinal polypeptide on nonadherent peripheral blood lymphocytes.
    Danek A; O'Dorisio MS; O'Dorisio TM; George JM
    J Immunol; 1983 Sep; 131(3):1173-7. PubMed ID: 6309960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bile salts on the plasma concentration of immunoreactive vasoactive intestinal polypeptide in man.
    Matsumura M; Saito S
    Endocrinol Jpn; 1989 Feb; 36(1):15-21. PubMed ID: 2731483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunoassay of plasma gastric inhibitory polypeptide (GIP), release of GIP after a test meal and duodenal infusion of bile, and immunoreactive plasma GIP components in man.
    Burhol PG; Jorde R; Waldum HL
    Digestion; 1980; 20(5):336-45. PubMed ID: 7390059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasoactive intestinal peptide inhibition of stimulated gastric secretion. I. Inhibition of meat-stimulated gastric secretion.
    Ebeid AM; Escourrou J; Fischer JE
    Am J Surg; 1980 Jun; 139(6):817-23. PubMed ID: 7386736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunoassay of plasma cholecystokinin (CCK), duodenal release of CCK, diurnal variation of plasma CCK, and immunoreactive plasma CCK components in man.
    Burhol PG; Rayford PL; Jorde R; Waldum HL; Schulz TB; Thompson JC
    Hepatogastroenterology; 1980 Aug; 27(4):300-9. PubMed ID: 7193631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.